Key Points1.miR-3144-5p is a target gene of *RANGRF*.2.A total of 571 genes are differentially expressed between miR-3144-5p mimic and control groups.3.*ISL1* and *NRG1* were enriched in cardiac muscle cell myoblast differentiation.4.*CCL21* is one of the hub genes in the PPI network.5.MYCN is involved in the miR-3144-5p-TF-target gene coregulatory network.

1. Introduction
===============

Cardiovascular diseases are the most common cause of mortality and morbidity worldwide.^\[[@R1]\]^ Among cardiovascular diseases, cardiac arrhythmia is a group of conditions in which the heart beat is irregular, including tachycardia (a heart rate more than 100 beats/min in adults) and bradycardia (a heart rate less than 60 beats/min). Most types of cardiac arrhythmia are not serious, but some types can predispose an individual to complications such as heart failure, stroke, or cardiac arrest, which are risk factors for life-threatening cardiac arrhythmias.^\[[@R2]\]^ Unfortunately, the molecular mechanisms underlying life-threatening cardiac arrhythmias have remained unclear until recently.

A recent study demonstrated a functional role for small noncoding RNAs (microRNAs) in the pathophysiology of cardiac arrhythmia.^\[[@R3]\]^ miRNAs are a group of small noncoding RNAs, mainly acting as suppressors of gene expression at the posttranscriptional level by binding to the 3′-untranslated region (UTR) of target mRNAs,^\[[@R4]\]^ the aberrant expression of which has been implicated in numerous diseases, including arrhythmogenesis.^\[[@R5],[@R6]\]^ miR-3144 is a recently identified miRNA located in the E6-encodingregion, which is reported to be dysregulated in several types of cancer.^\[[@R7]--[@R9]\]^ To our knowledge, its role in cardiovascular disease has not been reported. Interestingly, based on miRecord, a publicly available bioinformatic tool,^\[[@R10]\]^ miR-3144-5p was predicted to be a regulatory miRNA of RAN guanine nucleotide release factor (*RANGRF*), the gene encoding MOG1.^\[[@R11]\]^

MOG1 is a 187-amino-acid protein that can interact with intracellular loop II (between DII and DIII) of the pore-forming α subunit of the cardiac voltage-gated Na^+^ channel complex (Na~v~1.5), which is important for impulse conduction in the heart.^\[[@R11]\]^ The overexpression of MOG1 was shown to cause significant increases in Na~v~1.5 cell surface expression and whole-cell cardiac sodium currents.^\[[@R12]\]^ Na~v~1.5 is encoded by the sodium voltage-gated channel alpha subunit 5 (*SCN5A*) gene, and mutations in *SCN5A* have been associated with cardiac arrhythmias, such as atrial fibrillation, Brugada syndrome, and long QT syndrome.^\[[@R13]\]^ Therefore, MOG1 may be involved in the progression and development of cardiac arrhythmia.

Given the importance of MOG1 in cardiac arrhythmia, we speculated that the regulatory miRNAs of *RANGRF* may also play a role in arrhythmogenesis. Therefore, in this study, we first used a dual-luciferase reporter plasmid assay to verify the regulatory relationship between miR-3144-5p and *RANGRF* in human cardiac myocytes (HCMs). Then, we performed transcriptome sequencing and bioinformatic analyses to further investigate the functions of miR-3144-5p in HCMs. This study may provide a new insight into the mechanisms of arrhythmogenesis.

2. Materials and methods
========================

2.1. Cell culture and transfection
----------------------------------

The primary HCMs (6200) used in this study were purchased from ScienceCell (Carlsbad, CA), maintained in Dulbecco\'s modified Eagle\'s medium, and passaged by trypsinization. Then, cells at 70% confluence were seeded in 6-well plates before transfection. After 16 hours, cells were transfected with miR-3144-5 mimics and an miRNA mimic negative control (NC) using Lipofectamine 2000 (Invitrogen, Gaithersburg, MD), which was then confirmed by a real-time polymerase chain reaction (PCR) assay.

2.2. Real-time PCR assay
------------------------

miR-3144-5p expression in HCMs was detected using real-time PCR. Briefly, total RNA was extracted using RNA Iso-plus reagent (9019; Takara, Beijing, China). After measurement of the RNA concentration and purity, cDNA was synthesized using TIANscript RT Kit (KR201-01; Takara, Beijing, China). PCR amplification was performed using the SYBR Green PCR method, in accordance with the instructions of the SYBR Premix Ex Taq^TM^ Kit (Takara, Beijing, China). Each reaction was performed in triplicate. U6 was used as an internal control: U6-F, 5′-CTCGCTTCGGCAGCACA-3′ and U6-R, 5′-AACGCTTCACGAATTTGCGT-3′. The primers used for miR-3144-5p amplification were as follows: forward, 5′-AGGGGACCAAAGAGATATATAG-3′ and reverse, 5′-GCTGTCAACGATACGCTACCTA-3′.

2.3. Construction of luciferase reporter gene recombinant plasmid
-----------------------------------------------------------------

Based on *RANGRF* gene sequences in the National Center for Biotechnology Information database (<https://www.ncbi.nlm.nih.gov/>), the primers of RANGRF-3A-UTR were designed and synthesized by Sangon Biotech (Shanghai, China). The restriction enzyme cutting sites were added to the 5′ hend of primers. The primers were as follows: 4741RANGRF-F (XhoI), 57-AAGATCGCCGTGTGACTCGAGTCTCTTGCTTACCTTCAATCAGCC-3a, and 4741RANGRF-R (XbaI), 5′-AAGATCTGCGGCCGCTCTAGATATATTGATTATAAAGCAAGTTTATTCTGAAGAGG-3A. The *RANGRF* gene was amplified by PCR. Then, the products of PCR and the luciferase reporter plasmid pGL3 (Promega, Madison, WI) were digested using XhoI and XbaI. After measuring the concentrations of the target fragment and vector, they were recombined by seamless cloning. The products were then transformed into competent *Escherichia coli* cells and subjected to DNA sequencing to select a luciferasereporter gene recombinant plasmid.

2.4. Dual-luciferase reporter plasmid assay
-------------------------------------------

For the luciferase reporter assay, HCMs were plated in 96-well plates and cotransfected with luciferase reporter vectors. The pRL-TK plasmid containing the *Renilla* luciferase gene (Promega) was used as a normalizing control. After 48 hours of incubation, cells were lysed and assayed for luciferase activity using the Dual-Luciferase Reporter Assay System (Promega), in accordance with manufacturer\'s instructions.

2.5. RNA purification, library preparation, and sequencing
----------------------------------------------------------

Four samples, including 2 normal HCMs (control group: Con 1 and Con 2) and 2 transfected HCMs (test group: T1 and T2), were subjected to sequencing. Specifically, total RNA was extracted using Trizol (15596-018; Invitrogen); its integrity was verified using 2% agarose gel electrophoresis, while its quality and purity were evaluated using a spectrophotometer. Then, mRNA was isolated from 5 μg of total RNA using the NEBNext Poly (A) mRNA Magnetic Isolation Module (NEB \#E7490) and fragmented into small pieces (200 nt). The 1st-strand cDNA was synthesized using random hexamer primers. The cDNA was then converted into double-stranded cDNA, which was subsequently subjected to end repair, phosphorylation, dA tailing, and adaptor ligation. Finally, the cDNA library was generated, quantitated using quantitative PCR, and then sequenced on the Illumina HiSeq2500 platform.

The data are available at [ftp://119.57.118.228](ftp://119.57.118.228/) (username: shfhxx_lxs; password: ANCR0304).

2.6. Primary processing of raw reads and annotation of transcription
--------------------------------------------------------------------

The obtained raw reads were quality-filtered by removing the adaptor sequences and ambiguous or low-quality reads. The obtained clean reads were aligned to the human reference genome (hg19) using TopHat2.0.8 (<http://tophat.cbcb.umd.edu/>) with its default parameters. Based on human gene annotation information contained in the GeneCode database, the count values of reads of each gene were obtained using HTSeq-count 0.6.1p2 (<http://www-huber.embl.de/users/anders/HTSeq>). Finally, the read count matrices of 4 samples were identified.

2.7. Differentially expressed gene (DEG) analysis
-------------------------------------------------

The read count data were normalized based on the trimmed mean of M values of the edgeR^\[[@R14],[@R15]\]^ package and then converted into a gene expression matrix with the voom^\[[@R16]\]^ method in the limma^\[[@R17],[@R18]\]^ package. Voom can convert read count data into log2-counts per million, which can calculate the differences in expression levels between control and test groups using the linear model approach in the limma package. We calculated *P*-values regarding the significance of differences using moderated t-statistics. Cut-off values of *P*-value \<.05 and \|log~2~ (fold change)\| ≥0.58 were applied. The heatmap of DEGs was drawn using the Complex Heatmap^\[[@R19]\]^ package in R.

2.8. Functional enrichment analyses
-----------------------------------

Based on the obtained DEGs, Gene Ontology (GO), including biological process, molecular function, and cellular component categories, and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were carried out using the Database for Annotation, Visualization, and Integrated Discovery online tool (<http://david.abcc.ncifcrf.gov/>).^\[[@R20]\]^ Enrichment of GO functions and Kyoto Encyclopedia of Genes and Genomes pathways by at least 2 DEGs with a *P*-value \<.05 indicated significant enrichment results.

2.9. Protein--protein interaction (PPI) network analysis
--------------------------------------------------------

PPI analysis can help reveal the principles by which functional cellular networks are organized and provide new insights into protein functions.^\[[@R21]\]^ Therefore, we constructed a PPI network for further analysis of the DEGs. The Search Tool for the Retrieval of Interacting Genes/Proteins (STRING, <http://string-db.org/>)^\[[@R22]\]^ can predict the interactions among proteins encoded by the DEGs. The prediction methods of the STRING database come from Co-occurrence, Neighborhood, Co-expression Experiments, Gene Fusion, TextMining, and Database views. After inputting the DEGs into STRING, the PPI pairs were output to construct the PPI network using Cytoscape (<http://www.cytoscape.org/>) software.^\[[@R23]\]^

2.10. Analysis of topological features of nodes in PPI network
--------------------------------------------------------------

Most biological networks obey scale-free attribution.^\[[@R24]\]^ The important nodes in the PPI network were analyzed based on 3 methods of calculation of network topological features: degree centrality,^\[[@R25]\]^ betweenness centrality,^\[[@R26]\]^ and closeness centrality.^\[[@R27]\]^ The topology scores of nodes in the PPI network were calculated using the CytoNCA^\[[@R28]\]^ plugin of Cytoscape. The nodes with higher scores (hub nodes) may play important roles in the PPI network.

2.11. Analysis of target genes of miR-3144-5p
---------------------------------------------

The target genes of miR-3144-5p were predicted by the target module of the Mirwalk2 (<http://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2/>) database.^\[[@R29]\]^ The predicted miRNA-gene interaction pairs should appear in all 4 databases, namely miRWalk, miRanda, RNA22, and Targetscan 4. Subsequently, DEGs were selected from the predicted target genes to construct the miR-3144-5p-target DEG regulatory network.

2.12. miR-3144-5p-transcription factor (TF)-gene coregulatory network analysis
------------------------------------------------------------------------------

Based on the iRegulon^\[[@R30]\]^ plugin of Cytoscape, the TFs that regulate the target genes of miR-3144-5p were predicted. The parameter settings for iRegulon were minimum identity between orthologous genes:0.05, and maximum false discovery rate on motif similarity:0.001. The output results included normalized enrichment score (NES). A higher NES indicated a more reliable result. TF-target gene pairs with NES \>3 were selected in this study.

A study found that there were direct or indirect interactions between miRAN and TFs.^\[[@R31]\]^ Enright et al^\[[@R31]\]^ found that TFs were more likely to be targets of miRAN than normal genes. In this context, in this study TFs were selected from the target genes of miR-3144-5p, and miR-3144-5p-TF interaction pairs were obtained. Finally, TF-target gene interaction pairs and miR-3144-5p-TF interaction pairs were combined to construct the coregulatory network of miR-3144-5p-TF-gene.

2.13. Statistical analysis
--------------------------

Statistical analysis was conducted using SPSS 16.0 (SPSS, Inc., Chicago, IL). Data are expressed as mean ± standard error of the mean. Differences were analyzed using *t* test. Differences with *P* \< .05 were considered statistically significant.

3. Results
==========

3.1. miR-3144-5pis a direct regulatory miRNA of RANGRF
------------------------------------------------------

The bioinformatic tool miRecord predicted that miR-3144-5p is a regulatory miRNA of *RANGRF*. Dual-luciferase reporter plasmid assay was also used to confirm thatmiR-3144-5pbinds to the 3′-UTR of *RANGRF* mRNA. As shown in Fig. [1](#F1){ref-type="fig"}, miR-3144-5p significantly decreased the luciferase expression of 3′-UTR-RANGRF, suggesting that miR-3144-5pisa direct regulatory miRNA of *RANGRF* (*P* \< .05).

![The relative luciferase activity of miR-3144-5p detected using the dual-luciferase reporter plasmid assay. ^∗^*P* \< .05 compared to the negative control group.](medi-96-e7539-g001){#F1}

3.2. miR-3144-5p was low in HCMs
--------------------------------

The expression level of miR-3144-5p in HCMs was determined by qRT-PCR and was found to be low. However, after HCMs had been transfected with miR-3144-5p mimics, the relative expression level of miR-3144-5p increased significantly compared with that in the control (*P* \< .01) (Fig. [2](#F2){ref-type="fig"}).

![The relative expression level of miR-3144-5p in human cardiac myocytes after transfection, as determined by real-time polymerase chain reaction (RT-PCR). ^∗∗^*P* \< .01 compared to the negative control group.](medi-96-e7539-g002){#F2}

3.3. RNA-Seq data analysis
--------------------------

After Illumina HiSeq2500 sequencing, we obtained a global overview of the transcriptome of HCMs transfected withmiR-3144-5p mimics (T1 and T2)/NC (Con 1 and Con 2). The 4 samples had raw reads numbering between 40,925,500 and 42,600,828 with raw bases ranging from 6,138,825,000 to 6,390,124,200. After stringent filtration, 40,141,128, 40,014,762, 41,730,062, and 40,184,634 clean reads were obtained in T1, T2, Con 1, and Con 2, respectively. After mapping reads to the reference genome, we obtained the following read-mapping rates: the left end ranging from 91.96% to 92.58% and the right end ranging from 87.50% to 88.10%.

3.4. DEG analysis
-----------------

Based on the thresholds of a *P*-value \<.05 and \|log~2~ (fold change)\| ≥0.58, a total of 571 DEGs (300 upregulated and 271 downregulated) were obtained in the test group compared with the levels in the control group. The heatmap for these DEGs is shown in Fig. [3](#F3){ref-type="fig"}.

![Heatmap plot of differentially expressed genes across all samples. Columns represent genes and rows represent samples.](medi-96-e7539-g003){#F3}

3.5. Functional enrichment analyses
-----------------------------------

As shown in Fig. [4](#F4){ref-type="fig"}A, the upregulated DEGs were significantly enriched in the signaling pathways regulating the pluripotency of stem cells (hsa04550), the Hippo signaling pathway (hsa04390), and the Hedgehog signaling pathway (hsa04340). In particular, the upregulated ISL LIM homeobox 1 (*ISL1*) and neuregulin 1 (*NRG1*) were enriched in cardiac muscle cell myoblast differentiation (GO:0060379). The downregulated DEGs were significantly enriched in immunological synapse formation (GO:0001771), integral component of membrane (GO:0016021), and TGF-beta signaling pathway (hsa04350) (Fig. [4](#F4){ref-type="fig"}B).

![The CC, BP, and MF terms, and Kyoto Encyclopedia of Genes and Genomes pathways enriched with (A) upregulated and (B) downregulated differentially expressed genes. BP = biological process, CC = cellular component, MF = molecular function.](medi-96-e7539-g004){#F4}

3.6. PPI network analysis
-------------------------

A PPI network that comprised 255 nodes and 191 PPI pairs was constructed (Fig. [5](#F5){ref-type="fig"}). The top 25 nodes (hub nodes) with high topology scores are shown in Table [1](#T1){ref-type="table"}. Among these nodes, 15 gene nodes appeared 3 times because their topology scores in the 3 centrality methods were among the top 25, which included proopiomelanocortin (*POMC*), Wnt family member 4 (*WNT4*), Indian hedgehog (*IHH*), and C-C motif chemokine ligand 21 (*CCL21*). Functional enrichment analysis of these 15 genes revealed that they were associated with cell--cell signaling (GO:0007267), extracellular space (GO:0005615), receptor agonist activity (GO:0048018), and signaling pathways regulating the pluripotency of stem cells (hsa04550) (Table [2](#T2){ref-type="table"}).

![The protein--protein interaction network constructed using the differentially expressed genes. Red nodes represent upregulated genes and green nodes represent downregulated ones.](medi-96-e7539-g005){#F5}

###### 

The top 25 nodes with high topology scores that were calculated by 3 centrality methods in protein--protein interaction network.

![](medi-96-e7539-g006)

###### 

The CC, BP, and MF terms, and KEGG pathways enriched by 15 hub nodes in protein--protein interaction network.

![](medi-96-e7539-g007)

3.7. Analysis of target genes of miR-3144-5p
--------------------------------------------

A total of 15 target genes of miR-3144-5p were predicted, including 7 upregulated (*TMEM145*, *CST7*, *APOL4*, *DISC1*, *ARHGDIG*, *FAM110C*, and *MUC12*) and 8 downregulated ones (*GRTP1*, *PCDHGC4*, *CXorf36*, *SMOC1*, *RIMBP3*, *HOXB6*, *CCL21*, and *ALOXE3*). The constructed miR-3144-5p-target gene regulatory network is shown in Fig. [6](#F6){ref-type="fig"}.

![The miR-3144-5p-target gene regulatory network. Red nodes represent upregulated genes and green nodes represent downregulated ones. White triangles represent miRNA.](medi-96-e7539-g008){#F6}

3.8. miR-3144-5p-TF-targetgene coregulatory network analysis
------------------------------------------------------------

The miR-3144-5p-TF-target gene co-regulatory network was constructed (Fig. [7](#F7){ref-type="fig"}). This network included 11 DEGs (*HOXB6*, *CXorf36*, *CCL21*, *DISC1*, *ARHGDIG*, *RIMBP3*, *ALOXE3*, *GRTP1*, *MUC12*, *CST7*, and *SMOC1*) and 11 TFs (BCL3, ETV6, HMGA1, HOXA10, JUNB, KDM4C, KLF5, v-Myc avian myelocytomatosis viral oncogene neuroblastoma-derived homolog \[MYCN\], NFIC, POU2F3, and SREBF2).

![The miR-3144-5p-transcription factor-target gene coregulatory network. Red nodes represent upregulated genes and green nodes represent downregulated ones. White triangles represent miRNA and white rhombuses represent transcription factors. Black solid line represents the regulatory relationship between miR-3144-5p and the target gene. Purple dotted line represents the regulatory relationship between the transcription factor and the target gene.](medi-96-e7539-g009){#F7}

4. Discussion
=============

This study revealed that miR-3144-5p is a regulatory miRNA of *RANGRF*. Owing to the low expression level of miR-3144-5p in HCMs, we performed transfection with miR-3144-5p mimics to induce its overexpression in HCMs and then performed transcriptome sequencing. Bioinformatic analyses of the transcriptome sequencing results identified 300 upregulated and 271 downregulated DEGs. Among these, *ISL1* and *NRG1* were significantly enriched in cardiacmuscle cell myoblast differentiation (GO:0060379). *CCL21* was found to be a hub gene in the PPI network and also a target gene of miR-3144-5p. The TF MYCN is involved in the miR-3144-5p-TF-target gene coregulatory network and interacted with the target genes of miR-3144-5p.

miRNAs have emerged as ubiquitous regulators of a plethora of physiological and pathophysiological processes in cells.^\[[@R32]\]^ Numerous studies have implicated miRNAs in cardiovascular physiology and the onset of cardiovascular disease.^\[[@R33],[@R34]\]^ Additionally, Santulli et al^\[[@R3]\]^ reported that miRNAs regulated several properties of cardiac physiology and excitability, including automaticity, Ca^2+^ handling, conduction, and repolarization. In particular, a recent study unveiled an essential role of miRNAs in regulating cardiac arrhythmogenesis.^\[[@R35]\]^ The present study suggested that dysregulation of miR-3144-5p in HCMs induced hundreds of genes to be differently expressed, which may indicate the importance of miR-3144-5p in cardiac physiology.

Recent studies demonstrated an important role for ISL1 in anterior heart field development.^\[[@R36]\]^ Interestingly, *ISL1* was an upregulated DEG in this study; it was also suggested to be strongly linked with functions associated with cardiac muscle cell myoblast differentiation (GO:0060379). ISL1 was first identified as a key regulator of the *rat insulin I* gene enhancer and expressed in the endocrine cells of the pancreas.^\[[@R37]\]^ Recently, it was defined as a marker of the cardiac progenitor cell lineage that can differentiate into cardiomyocyte, smooth muscle cell, and endothelialcell lineages of the heart.^\[[@R38]\]^ Cai et al^\[[@R36]\]^ found that Isl1 knockout mice have a severely deformed heart, suggesting the importance of ISL1 in this organ. Therefore, we speculated that miR-3144-5p overexpression may lead to the upregulation of *ISL1*, which in turn plays a role in HCMs.

In addition to *ISL1*, *NRG1* was also suggested to be associated with cardiac muscle cell myoblast differentiation. NRG1 belongs to the neuregulin family, which consists of ErbB1, 2, 3, and 4. NRG1 is also an agonist for receptor tyrosine kinases of the epidermal growth factor receptor family.^\[[@R39]\]^ Studies have found that it is essential for normal development of the nervous system and the heart.^\[[@R40],[@R41]\]^ NRG1 plays multiple roles in cardiovascular biology and has been suggested to be a cardiomyocyte mitogen, stimulating heart muscle cells to divide.^\[[@R42]\]^ Wang et al^\[[@R43]\]^ have reported that NRG1 can induce embryonic stem cells to differentiate into cardiomyocytes. Taking these findings together, miR-3144-5p overexpression may induce NRG1 to regulate the function of HCMs.

Enhanced circulating levels of C-C chemokines reportedly play a pathogenic role in congestive heart failure.^\[[@R44]\]^ In this study, a C-C chemokine, CCL21, was identified to be one of the hub nodes that had high topology scores in 3 centrality methods in the PPI network. Specifically, it was predicted to be a target gene of miR-3144-5p. A study found that CCL21 elicits its effect through binding to a cell surface chemokine receptor, namely C-C chemokine receptor 7.^\[[@R45]\]^ C-C chemokine receptor 7 and its ligands were previously shown to be related to the development of heart failure. Additionally, markedly enhanced CCL21 expression was found within the failing myocardium in human heart failure. It has served as a potential mediator in myocardial failure.^\[[@R46]\]^ Given the regulatory relationship between miR-3144-5p and *CCL21* and the role of CCL21 in heart failure, we speculated that miR-3144-5p may play a role in the function of HCMs by targeting *CCL21*.

The TF MYCN was included in the miR-3144-5p-TF-target gene coregulatory network, which suggested that miR-3144-5p interacts with MYCN, thereby playing a role in HCMs. MYCN is a member of the MYC family of TFs, with a basic helix--loop--helix domain. It has to dimerize with another basic helix--loop--helix protein to bind DNA.^\[[@R47]\]^ Importantly, MYCN has been found to be necessary for the expression of myofilament proteins, which are important for the structure and function of cardiomyocytes. MYCN promotes the proliferation and growth of cardiomyocytes by regulating the expression of cell cycle regulators and p70S6K, respectively.^\[[@R48]\]^ A study also suggested that mutations in MYCN are involved in Feingold syndrome, a disorder associated with congenital heart defects.^\[[@R49]\]^ Taking these findings together, miR-3144-5p may regulate the expression of MYCN to impact the functions of HCMs.

Although so many genes had been predicted to be differentially expressed in HCMs with miR-3144-5p overexpression, the exact expression levels of these DEGs and TF, especially *ISL1*, *NRG1*, *CCL21*, and MYCN were not confirmed in the experimental study. Additionally, due to high cost of high-throughput sequencing, the sample size was usually small. Therefore, our further study will focus on the functional roles of miR-3144-5p as well as the key DEGs in cardiac arrhythmia based on more samples of animal models to validate our results.

In conclusion, *ISL1*, *NRG1*, *CCL21*, and MYCN were differentially expressed in the miR-3144-5p mimic group, which suggested that miR-3144-5p overexpression plays a role in HCMs by regulating the expression of these genes and TF. The findings in this study may provide a new insight into the molecular mechanisms underlying the progression of cardiac arrhythmia.
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